https://www.ambergen.com/wp-content/uploads/logo-retina.png 0 0 Kenneth Rothschild https://www.ambergen.com/wp-content/uploads/logo-retina.png Kenneth Rothschild2012-10-15 13:44:152016-11-10 12:44:44AmberGen receives US Patent 8,278,045 for detecting chain truncation mutations which cause breast and colorectal cancer
Get in Touch
313 Pleasant St.
Watertown, MA 02472
- AmberGen announces that Dr. Michael Easterling, PhD will join Board of Directors April 2022
- AmberGen Announces New Appointments for John Gillespie & Dr. Kenneth J. Rothschild April 2022
- AmberGen and Bruker Collaborate on Spatial Biology Imaging Reagents for MALDI-Immunohistochemistry (MALDI-IHC) April 2022
- Dr. Mark Lim of AmberGen was honored to be an invited keynote speaker at the “Innovation in Mass Spectrometry Imaging Omics” Session March 2022